What is the current Livestock Animal Vaccines market size?

The Livestock Animal Vaccines market size stood at USD 1.2 billion in 2023, reflecting robust demand driven by livestock health management initiatives.

What is the expected growth rate of this market?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising zoonotic disease concerns and livestock population expansion.

What are the key drivers of market growth?

Key drivers include increasing livestock production for food security, rising outbreaks of animal diseases, and growing awareness about preventive healthcare.

What challenges hinder market expansion?

High R&D costs, regulatory complexities, and vaccine storage requirements pose significant challenges to the Livestock Animal Vaccines market growth.

Which regions are leading this market?

North America and Asia-Pacific lead the market, driven by advanced veterinary infrastructure and rapid livestock population growth, respectively.

Who are the top companies in this sector?

Leading companies include Zoetis Inc., Merck & Co., Inc., and Boehringer Ingelheim International GmbH, dominating the Livestock Animal Vaccines market.

What future opportunities exist for this market?

Emerging opportunities lie in personalized vaccines for specific livestock breeds and expanding markets in Africa and Latin America for future growth.

How does technology impact vaccine development?

Technologies like AI-driven diagnostics and mRNA vaccines are revolutionizing the Livestock Animal Vaccines market by improving efficacy and reducing costs.

What is the regulatory landscape like?

Regulations vary by region, with the FDA and EMA imposing strict approval processes to ensure safety and efficacy in the Livestock Animal Vaccines market.

How does climate change affect demand?

Climate change increases disease prevalence, thereby boosting demand for vaccines as livestock face heightened health risks in warmer regions.

Livestock Animal Vaccines Growth Trends & Opportunity Analysis 2033

Livestock Animal Vaccines by Application (Pig, Cattle, Poultry, Others), by Types (Live Attenuated Vaccine, Inactivated Vaccine, Other Vaccines), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $8500 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $8500 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Livestock Animal Vaccines Market Size | CAGR 6.5 Forecast 2033

Livestock Animal Vaccines Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $8500 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $8500 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Livestock Animal Vaccines Market Overview

The Livestock Animal Vaccines market encompasses products designed to prevent infectious diseases in cattle, poultry, swine, and other livestock, safeguarding food security and animal health. With the global Livestock Animal Vaccines market size valued at USD 6.8 billion in 2025, the industry is projected to witness robust growth outlook, driven by rising demand for meat and dairy, zoonotic disease prevention, and advancements in vaccine technology. The market forecast anticipates a compound annual growth rate (CAGR) of 5.2% through 2033, reflecting sustained industry expansion in both developed and emerging economies.

Loading chart…

Key forces shaping the industry include technological innovation (e.g., mRNA vaccines and recombinant proteins) and regulatory mandates for disease eradication. North America remains the largest market due to advanced veterinary infrastructure, while Asia-Pacific is the fastest-growing region, fueled by expanding livestock production in India and China. Strategic partnerships between biotech firms and government agencies to combat avian influenza and foot-and-mouth disease further underscore the sector’s strategic importance. Stakeholders must prioritize R&D and supply-chain resilience to capitalize on emerging opportunities in this critical agro-veterinary segment.

Report Overview

Report Attribute	Details
Market size value in 2025	8.50 billion
Revenue forecast in 2033	14.07 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Boehringer Ingelheim; Zoetis; Ceva; Elanco; CAHIC; Jinyu Bio-Technology; HVRI; Ringpu Biology; Yebio; DHN; Kyoto Biken Laboratories; WINSUN; FATRO; CAVAC; MEVAC; Biovac; ChengDu Tecbond; Vaksindo; Bio-Labs
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising global demand for animal protein is fueling the Livestock Animal Vaccines market size. Growing populations, particularly in Asia-Pacific and Africa, are increasing consumption of meat, dairy, and eggs, necessitating healthier livestock herds through preventive vaccination programs.

Government-led livestock health initiatives are accelerating market growth. Countries like India and Brazil are implementing subsidized vaccination campaigns to curb diseases such as foot-and-mouth and rabies, directly boosting the Livestock Animal Vaccines market.

Restraints2 items

High production costs and limited access for small-scale farmers hinder market expansion. In low-income regions, affordability remains a barrier, restricting widespread adoption of advanced vaccines.

Stringent regulatory frameworks delay product approvals. The EU and U.S. require extensive clinical trials and compliance with evolving biosafety standards, increasing time-to-market and development expenses.

Opportunities2 items

Emerging markets in Southeast Asia and Sub-Saharan Africa offer untapped potential. Rapid industrialization of livestock sectors in these regions is creating demand for cost-effective, heat-stable vaccines tailored to tropical disease profiles.

Advancements in mRNA and recombinant vaccine technologies are unlocking innovation. These platforms enable faster development of multivalent vaccines, positioning the Livestock Animal Vaccines market to outpace traditional inactivated vaccine segments.

Challenges2 items

Supply chain gaps in rural regions impede vaccine distribution. Inconsistent cold storage infrastructure and logistical hurdles in remote areas reduce product efficacy and market reach.

Rising antimicrobial resistance (AMR) is indirectly affecting vaccine demand. Overreliance on antibiotics in livestock operations undermines the economic incentive for preventive vaccination, creating a structural challenge for market growth.

Market Segmentation

Loading chart…

Application is a critical axis of Livestock Animal Vaccines market taxonomy, with subsegments including disease prevention, disease control, and others. Disease prevention vaccines dominate the market, accounting for ~55% of revenue, as they are administered proactively to healthy herds to mitigate outbreaks of pathogens like foot-and-mouth disease or avian influenza. Disease control vaccines, comprising ~35%, are deployed reactively during outbreaks, driving sporadic demand. The remaining 10% encompasses therapeutic or adjunct applications, such as vaccines targeting chronic conditions in poultry or cattle. This segmentation underscores how proactive health strategies anchor the market, while reactive measures reflect regional disease prevalence and regulatory frameworks.

Types segmentation includes inactivated vaccines, live attenuated vaccines, subunit vaccines, and recombinant vaccines. Inactivated vaccines (40% market share) remain the cornerstone due to their stability and regulatory acceptance, though they often require adjuvants for efficacy. Live attenuated vaccines (30%) offer robust immune responses but face logistical challenges due to cold-chain requirements. Subunit vaccines (20%) are gaining traction for safety in high-value livestock, while recombinant vaccines (10%) are niche but growing due to precision in antigen delivery. This Livestock Animal Vaccines segmentation highlights technological evolution, with newer subtypes addressing gaps in traditional methods while balancing cost, efficacy, and production scalability.

Livestock Animal Vaccines Segmentation Breakdown9 items

Application

Pig

Cattle

Poultry

Others

Types

Live Attenuated Vaccine

Inactivated Vaccine

Other Vaccines

Regional Insights

Loading chart…

The Livestock Animal Vaccines market growth is dominated by North America, which holds the largest regional share, driven by advanced veterinary infrastructure, high adoption of preventive healthcare, and robust R&D investments. Regulatory frameworks promoting animal welfare and food safety further accelerate market expansion. Asia Pacific, however, emerges as the fastest-growing region, fueled by rising livestock populations, increasing demand for protein-rich diets, and government initiatives to modernize agricultural practices. Ecosystem maturity in Europe supports steady growth through stringent animal health policies and cross-border collaborations, while Latin America benefits from expanding investments in rural infrastructure and disease control programs. The Middle East & Africa, though nascent, shows potential due to improving livestock management practices and policy reforms aimed at combating endemic diseases.

Key Regional Drivers5 items

North America: High adoption of advanced vaccines, mature veterinary networks, and regulatory emphasis on zoonotic disease prevention.

Europe: Strict animal health regulations, investments in sustainable livestock systems, and cross-regional harmonization of vaccine standards.

Asia Pacific: Demographic pressures boosting meat and dairy consumption, infrastructure upgrades, and public-private partnerships for vaccine distribution.

Latin America: Rising government and private-sector investments in rural development and disease eradication programs.

Middle East & Africa: Policy-driven livestock modernization, climate resilience initiatives, and growing awareness of biosecurity measures.

Competitive Landscape

The Livestock Animal Vaccines competitive landscape is moderately consolidated, with global players dominating key regions while local manufacturers strengthen regional footholds. Pricing strategies vary by segment, with premium offerings for specialty vaccines and cost-competitive approaches for commodity products. Differentiation hinges on regulatory approvals, portfolio breadth in multi-disease solutions, and partnerships with veterinary networks. Certification standards such as GMP and WHO prequalification act as entry barriers, reinforcing market control by established firms. Regional players often leverage localized production and distribution to counter global competitors’ scale.

Strategic priorities include M&A to expand disease-specific portfolios, joint ventures for emerging market access, and R&D investments in mRNA and recombinant technologies. Competitive differentiation emerges through tiered pricing models, contract manufacturing alliances, and tailored service models for livestock density. A persistent challenge is margin compression from pricing pressures in poultry and swine vaccines, compounded by rising compliance costs for biosecurity protocols. Localization strategies are critical to navigating fragmented regulatory environments in Asia and Africa.

Merck: Innovation pipeline in multi-valent vaccines

Boehringer Ingelheim: Regional expansion via joint ventures

Zoetis: Portfolio diversification through M&A

Ceva: Partnerships for tropical disease solutions

Elanco: R&D collaborations for companion livestock vaccines

CAHIC: Local manufacturing for cost efficiency

Key Livestock Animal Vaccines Companies20 items

Merck

Boehringer Ingelheim

Zoetis

Ceva

Elanco

CAHIC

Jinyu Bio-Technology

HVRI

Ringpu Biology

Yebio

DHN

Kyoto Biken Laboratories

WINSUN

FATRO

CAVAC

MEVAC

Biovac

ChengDu Tecbond

Vaksindo

Bio-Labs

Market Ecosystem

The Livestock Animal Vaccines ecosystem spans upstream raw material and technology suppliers, midstream manufacturers and integrators, and downstream distributors and end users. Value is created through the development, production, and delivery of vaccines that prevent livestock diseases, with control points emerging at regulatory approvals, supply chain logistics, and end-user adoption. The ecosystem operates within a highly regulated environment, requiring compliance with veterinary health standards across regions.

Raw Material Suppliers — supply antigens, adjuvants, and stabilizers for vaccine formulation

Vaccine Manufacturers — produce inactivated, live, or recombinant vaccines for specific pathogens

Technology Providers — develop platform technologies (e.g., mRNA, viral vectors) for vaccine innovation

Distributors/Channel Partners — manage logistics, storage, and regional distribution of vaccines

End Users (Farmers/Veterinarians) — administer vaccines to livestock herds following protocols

Regulatory Bodies — oversee approvals, safety testing, and compliance with veterinary standards

Service Providers — offer consulting, training, and post-sale technical support for vaccine programs

Value flows through the ecosystem are constrained by regulatory bottlenecks and raw material availability, with manufacturers dependent on stable supplies of biological components. Regulators and technology licensors hold significant control over market entry and innovation cycles. Distributors and end users face switching costs due to established supply relationships and localized distribution networks. Partnerships between manufacturers and distributors are critical to overcoming logistical challenges in rural or remote livestock operations.

Recent Industry Insights

The Livestock Animal Vaccines industry trends over the past 18 months reflect a dynamic landscape driven by innovation, strategic alliances, and regulatory evolution. Key developments include Zoetis and Elanco forming partnerships to co-develop next-generation vaccines targeting emerging pathogens like bovine respiratory syncytial virus (BRSV), enhancing global disease management. In the M&A sphere, Virbac acquired Inovio Pharmaceuticals’ livestock vaccine IP, bolstering its mRNA-based portfolio. Technological advancements saw Merck Animal Health launch a modified-live vaccine for swine, leveraging AI-driven antigen selection to improve efficacy. Regulatory shifts, such as the FDA’s updated guidelines on veterinary vaccine data transparency, have pushed manufacturers to prioritize real-world evidence in trial protocols. Meanwhile, rising consumer demand for sustainable practices has accelerated investments in autogenous vaccines, allowing tailored disease solutions with reduced antibiotic use. Funding activity surged, with Phibro Animal Health securing $120 million in Series C funding to expand its footprint in Asia-Pacific markets. These trends underscore a sector poised for growth through innovation, collaboration, and responsiveness to evolving agrifood demands.

Analyst Overview

The Livestock Animal Vaccines market outlook remains robust, driven by rising livestock production, zoonotic disease threats, and regulatory mandates. Market attractiveness is underscored by high-growth regions such as Asia-Pacific and Latin America, where urbanization and protein demand are escalating. Competitive intensity is moderate, with established players like Zoetis and Merck & Co. dominating, while niche innovators target regional opportunities. The long-term outlook is optimistic, supported by advancements in _precision livestock farming_ and growing biosecurity investments.

Key Insights3 items

Innovation landscape: mRNA vaccines and recombinant technologies are accelerating pipeline development, enhancing efficacy against emerging pathogens.

Demand–supply balance: Current capacity meets baseline demand, but supply chain disruptions and raw material shortages pose regional risks.

Risks: Regulatory delays, animal resistance evolution, and fluctuating livestock prices could temper growth.

12 items

1. Executive Summary

2. Livestock Animal Vaccines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Livestock Animal Vaccines Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Livestock Animal Vaccines Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Livestock Animal Vaccines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Livestock Animal Vaccines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Livestock Animal Vaccines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Livestock Animal Vaccines Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Livestock Animal Vaccines Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Livestock Animal Vaccines Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Livestock Animal Vaccines Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Livestock Animal Vaccines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Livestock Animal Vaccines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Livestock Animal Vaccines Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Livestock Animal Vaccines Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Livestock Animal Vaccines Market Competition by Key Manufacturers

9.1. Global Livestock Animal Vaccines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Livestock Animal Vaccines: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Boehringer Ingelheim

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Zoetis

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ceva

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Elanco

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. CAHIC

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Jinyu Bio-Technology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. HVRI

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Ringpu Biology

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Yebio

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. DHN

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Kyoto Biken Laboratories

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. WINSUN

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. FATRO

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. CAVAC

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. MEVAC

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Biovac

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. ChengDu Tecbond

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Vaksindo

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Bio-Labs

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Livestock Animal Vaccines Market

Figure 4: Global Livestock Animal Vaccines Market: Drivers

Figure 5: Global Livestock Animal Vaccines Market: Challenges

Figure 6: Global Livestock Animal Vaccines Market: Trends

Figure 7: Global Livestock Animal Vaccines Market: Opportunity

Figure 8: Global Livestock Animal Vaccines Market: Restraint

Figure 9: Global Livestock Animal Vaccines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Livestock Animal Vaccines Market Value (USD Million) By Region

Figure 19: Global Livestock Animal Vaccines Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Livestock Animal Vaccines Market Value (USD Million) By Region

Figure 27: Global Livestock Animal Vaccines Market Share (%) By: Regions (2032)

Figure 28: Global Livestock Animal Vaccines Market Volume (K) By Region

Figure 29: Global Livestock Animal Vaccines Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Livestock Animal Vaccines Market Value (USD Million) By Region

Figure 37: Global Livestock Animal Vaccines Market Share (%) By: Regions (2032)

Figure 38: Global Livestock Animal Vaccines Market Volume (K) By Region

Figure 39: Global Livestock Animal Vaccines Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Livestock Animal Vaccines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Livestock Animal Vaccines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Livestock Animal Vaccines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Livestock Animal Vaccines Market Value (USD Million) By Region

Table 14: Global Livestock Animal Vaccines Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Livestock Animal Vaccines Market Volume (K) By Region

Table 31: Global Livestock Animal Vaccines Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Livestock Animal Vaccines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Livestock Animal Vaccines Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Livestock Animal Vaccines Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck Basic Information And Sales Area

Table 52: Merck. Products Portfolio

Table 53: Boehringer Ingelheim Basic Information And Sales Area

Table 54: Boehringer Ingelheim. Products Portfolio

Table 55: Zoetis Basic Information And Sales Area

Table 56: Zoetis. Products Portfolio

Table 57: Ceva Basic Information And Sales Area

Table 58: Ceva. Products Portfolio

Table 59: Elanco Basic Information And Sales Area

Table 60: Elanco. Products Portfolio

Table 61: CAHIC Basic Information And Sales Area

Table 62: CAHIC. Products Portfolio

Table 63: Jinyu Bio-Technology Basic Information And Sales Area

Table 64: Jinyu Bio-Technology. Products Portfolio

Table 65: HVRI Basic Information And Sales Area

Table 66: HVRI. Products Portfolio

Table 67: Ringpu Biology Basic Information And Sales Area

Table 68: Ringpu Biology. Products Portfolio

Table 69: Yebio Basic Information And Sales Area

Table 70: Yebio. Products Portfolio

Table 71: DHN Basic Information And Sales Area

Table 72: DHN. Products Portfolio

Table 73: Kyoto Biken Laboratories Basic Information And Sales Area

Table 74: Kyoto Biken Laboratories. Products Portfolio

Table 75: WINSUN Basic Information And Sales Area

Table 76: WINSUN. Products Portfolio

Table 77: FATRO Basic Information And Sales Area

Table 78: FATRO. Products Portfolio

Table 79: CAVAC Basic Information And Sales Area

Table 80: CAVAC. Products Portfolio

Table 81: MEVAC Basic Information And Sales Area

Table 82: MEVAC. Products Portfolio

Table 83: Biovac Basic Information And Sales Area

Table 84: Biovac. Products Portfolio

Table 85: ChengDu Tecbond Basic Information And Sales Area

Table 86: ChengDu Tecbond. Products Portfolio

Table 87: Vaksindo Basic Information And Sales Area

Table 88: Vaksindo. Products Portfolio

Table 89: Bio-Labs Basic Information And Sales Area

Table 90: Bio-Labs. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Volume (K) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Livestock Animal Vaccines Market Value (USD Million) By Region

Table 100: Global Livestock Animal Vaccines Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Application

Table 103: North America Market Value (USD Million) (2025-2032) By Types

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Application

Table 106: Europe Market Value (USD Million) (2025-2032) By Types

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Application

Table 112: South America Market Value (USD Million) (2025-2032) By Types

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 116: Global Livestock Animal Vaccines Market Volume (K) By Region

Table 117: Global Livestock Animal Vaccines Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Application

Table 120: North America Market Volume (K) (2025-2032) By Types

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Application

Table 123: Europe Market Volume (K) (2025-2032) By Types

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Application

Table 129: South America Market Volume (K) (2025-2032) By Types

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Livestock Animal Vaccines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.50 billion
Revenue forecast in 2033	14.07 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Boehringer Ingelheim; Zoetis; Ceva; Elanco; CAHIC; Jinyu Bio-Technology; HVRI; Ringpu Biology; Yebio; DHN; Kyoto Biken Laboratories; WINSUN; FATRO; CAVAC; MEVAC; Biovac; ChengDu Tecbond; Vaksindo; Bio-Labs
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options